Envoy Medical wins new Canadian, Hong Kong patents, lifts global total to 97
COCH•New patent grants expand Envoy Medical's portfolio
Envoy Medical reported two newly granted international patents, lifting its global total to 97 granted patents as of Sept. 22, 2026.
- The additions include one Canadian patent covering integrated implantable cochlear components, lead characterization, and conductor testing within the system.
- A Hong Kong patent covers methods to compensate for variability in a middle-ear sensor, including signal processing to normalize sensor output.
- The portfolio now includes 40 granted U.S. patents, 57 granted foreign patents, and 35 pending applications, supporting its fully implanted hearing platform.




